BioSpace News Archive

Biotech Beach

Eurofins Discovery Elevates Its Impact in San Diego’s Innovation Ecosystem by Enrolling as a Founding Sponsor of BioLabs, San Diego

As a BioLabs founding sponsor Eurofins Discovery provides services and support for start-ups in San Diego to accelerate their early-stage drug discovery programs

October 30, 2019
·
7 min read
Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®

The Tufts CSDD study assessed development cycle times and their financial benefits by using data compiled on completed Translational Pharmaceutics projects to benchmark against industry drug development durations.

October 30, 2019
·
3 min read
Policy

EMA and FDA Accept Marketing Applications for Chugai’s Satralizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

NMOSD is a rare disease where repeated relapses may result in visual impairment and motor disability in the course of disease progression.

October 30, 2019
·
5 min read
Business

LEO Pharma Enters Into Option Agreement With Ubiquigent for Access to Novel Compounds

Ubiquigent Limited and LEO Pharma A/S announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.

October 30, 2019
·
3 min read
Drug Development

Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS)

CMS-001 trial is the first and only double-blinded, placebo-controlled study ever conducted in genetically confirmed CMS patients

October 30, 2019
·
6 min read
BioMidwest

SVS - Patients with artery disease are taking more painkillers, but reasons are complex

A large new study has found that an artery disease that mostly affects legs and feet is associated with increased use of opioids, the Society for Vascular Surgery reports.

October 30, 2019
·
3 min read
Business

Cancer organization brings wider range of health expertise to Board of Directors

The Canadian Partnership Against Cancer has elected eight new board members creating a leadership group from all parts of the country and skilled in unique areas of the cancer experience

October 30, 2019
·
4 min read
Policy

European Commission Approves Astellas’ XOSPATA™ for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay

Invivoscribe, Inc. announced that the European Commission has approved the Astellas drug XOSPATA™ as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with FLT3 mutations detected using Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay..

October 30, 2019
·
4 min read
BioCapital

Cystic Fibrosis Foundation Launches $500 Million Path to a Cure

The Cystic Fibrosis Foundation unveiled its Path to a Cure, an ambitious research agenda to deliver treatments for the underlying cause of the disease and a cure for every person with cystic fibrosis (CF).

October 30, 2019
·
4 min read
Business

United Therapeutics Corporation Reports Third Quarter 2019 Financial Results

United Therapeutics Corporation announced its financial results for the quarter ended September 30, 2019.

October 30, 2019
·
14 min read